John G. Cooper's most recent trade in Rockwell Medical Inc was a trade of 5,079 Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on Nov. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rockwell Medical Inc | John G. Cooper | Director | Sale of securities on an exchange or to another person at price $ 0.87 per share. | 18 Nov 2025 | 5,079 | 140,372 (0%) | 0% | 0.9 | 4,419 | Common Stock |
| Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 50,000 | 145,451 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 36,111 | 95,451 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 24,715 | 155,594 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 25,000 | 130,879 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 72,857 | 72,857 | - | - | Stock Option (Right to Buy) | |
| Rockwell Medical Inc | John G. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 50,000 | 105,879 (0%) | 0% | 0 | Common Stock |